Leidos is a science and technology solutions leader working to address some of the world’s toughest challenges in national security, health, and engineering. Leidos designs and develops high-technology products. These products include customized and standard hardware and software, such as automatic equipment identification technology, sensors and nondestructive imaging and security instruments and more.

Type
Public
HQ
Reston, US
Founded
1969
Size (employees)
33,000 (est)+216%
Website
leidos.com
Leidos was founded in 1969 and is headquartered in Reston, US

Key People at Leidos

Roger A. Krone

Roger A. Krone

Chairman & Chief Executive Officer
James C. Reagan

James C. Reagan

Chief Financial Officer
John Fratamico

John Fratamico

Chief Technology Officer
Mary Craft

Mary Craft

Chief Administrative Officer
Gerry Fasano

Gerry Fasano

Chief of Business Development & Strategy
Michele M. Brown

Michele M. Brown

Chief Ethics & Compliance Officer

Leidos Office Locations

Leidos has an office in Reston
Reston, US (HQ)
11951 Freedom Dr

Leidos Data and Metrics

Leidos Financial Metrics

Leidos's revenue was reported to be $2.6 b in Q1, 2017
USD

Revenue (Q1, 2017)

2.6 b

Gross profit (Q1, 2017)

310 m

Gross profit margin (Q1, 2017), %

12%

Net income (Q1, 2017)

74 m

EBIT (Q1, 2017)

141 m

Market capitalization (17-Aug-2017)

8.4 b

Cash (31-Mar-2017)

206 m
Leidos's current market capitalization is $8.4 b.
USDY, 2014FY, 2015FY, 2016

Revenue

5.8 b5.1 b7 b

Revenue growth, %

(12%)39%

Cost of goods sold

4.1 b

Gross profit

2.9 b

Gross profit Margin, %

41%

General and administrative expense

201 m

Operating expense total

201 m

EBIT

(214 m)320 m

EBIT margin, %

(4%)5%

Interest expense

(53 m)

Interest income

4 m

Pre tax profit

355 m

Income tax expense

(112 m)

Net Income

(323 m)246 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

1.3 b1.3 b1.2 b1.3 b1.3 q1.3 b1.3 b1.9 b2.6 b

Cost of goods sold

1.1 b1.1 b1.1 b1.1 b1.1 q1.2 b1.1 b1.6 b2.3 b

Gross profit

187 m161 m153 m144 m160 t158 m147 m238 m310 m

Gross profit Margin, %

14%13%12%11%12%12%11%13%12%

General and administrative expense

87 m72 m75 m51 m53 t60 m57 m87 m144 m

Operating expense total

87 m72 m75 m51 m53 t60 m57 m87 m144 m

EBIT

(410 m)72 m38 m64 m94 t89 m75 m101 m141 m

EBIT margin, %

(31%)6%3%5%7%7%6%5%5%

Interest expense

(20 m)(18 m)(14 m)(14 m)(14 t)(11 m)(13 m)(28 m)(38 m)

Interest income

1 m3 m2 m

Pre tax profit

(430 m)54 m23 m52 m80 t78 m60 m75 m108 m

Income tax expense

(9 m)(16 m)(15 m)(31 t)(29 m)(19 m)17 m(34 m)

Net Income

(438 m)34 m41 m37 m49 t49 m41 m92 m74 m
USDFY, 2014FY, 2015FY, 2016

Cash

430 m443 m376 m

Current Assets

1.8 b1.6 b2.4 b

PP&E

483 m308 m259 m

Goodwill

1.7 b1.2 b4.6 b

Total Assets

4.2 b3.3 b9.1 b

Accounts Payable

1.4 b

Dividends Payable

23 m

Current Liabilities

1 b951 m2 b

Additional Paid-in Capital

1.6 b1.4 b3.3 b

Retained Earnings

25 m(177 m)

Total Equity

1.6 b998 m3.1 b

Financial Leverage

2.6 x3.3 x2.9 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

358 m418 m377 m365 m635 m609 m670 m449 m206 m

Current Assets

1.7 b1.7 b1.7 b1.7 b1.7 b1.8 b1.8 b2.6 b2.4 b

PP&E

231 m238 m

Goodwill

1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b4.9 b4.6 b

Total Assets

3.5 b3.4 b3.3 b3.2 b3.3 b3.4 b3.4 b9.6 b9.1 b

Accounts Payable

682 m704 m745 m716 m771 m707 m720 m1.5 b592 m

Dividends Payable

23 m21 m

Current Liabilities

991 m1 b987 m996 m1 b1 b990 m2 b2 b

Additional Paid-in Capital

1.4 b1.4 b1.4 b1.3 b1.3 b1.4 b1.4 b3.3 b3.3 b

Retained Earnings

(419 m)(406 m)(380 m)(251 m)(230 m)(188 m)(154 m)

Total Equity

919 m954 m1.1 b1.1 b3.1 b3.2 b

Financial Leverage

3.5 x3.5 x3.1 x3 x3.1 x2.9 x
USDFY, 2014FY, 2015FY, 2016

Net Income

164 m(323 m)242 m

Depreciation and Amortization

81 m62 m41 m

Cash From Operating Activities

13 m

Purchases of PP&E

(53 m)(29 m)(27 m)

Long-term Borrowings

(39 m)

Dividends Paid

(95 m)(93 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(438 m)34 m41 m37 m49 t49 m41 m92 m74 m

Accounts Payable

592 m
USDY, 2017

Revenue/Employee

78.2 k

Financial Leverage

2.9 x

Leidos Operating Metrics

Leidos's Locations was reported to be 341 in FY, 2016, which is a 44% increase from the previous period
Q1, 2014Q2, 2014Q3, 2014FY, 2014Q1, 2015Q2, 2015Q3, 2015FY, 2015Q1, 2016Q2, 2016Q3, 2016FY, 2016Q1, 2017

Bookings

$8.84 b$8.41 b$8.33 b$9.3 b$7.47 b$10.22 b$10.47 b$7.79 b$9.61 b$8.97 b$18.66 b$17.74 b$1.7 b

Locations

267236341

Leidos Market Value History

Leidos Revenue Breakdown

Leidos Median Salaries

Source: 158 public H-1B filings from Leidos

Traffic Overview of Leidos

Leidos Online and Social Media Presence

Leidos News and Updates

BRIEF-Immunovaccine awarded subcontract to evaluate depovax for development of malaria vaccine targets

* Awarded a subcontract by leidos to evaluate immunovaccine's depovax(tm) platform for development of peptide based malaria vaccine targets Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Leidos Company Life and Culture

You may also be interested in